These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12925371)

  • 1. Reliability of 4 outcome measures in pediatric spinal muscular atrophy.
    Iannaccone ST; Hynan LS;
    Arch Neurol; 2003 Aug; 60(8):1130-6. PubMed ID: 12925371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome measures for pediatric spinal muscular atrophy.
    Iannaccone ST;
    Arch Neurol; 2002 Sep; 59(9):1445-50. PubMed ID: 12223032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.
    Nelson L; Owens H; Hynan LS; Iannaccone ST;
    Neuromuscul Disord; 2006 Jun; 16(6):374-80. PubMed ID: 16632361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome measures in spinal muscular atrophy.
    Montes J; Gordon AM; Pandya S; De Vivo DC; Kaufmann P
    J Child Neurol; 2009 Aug; 24(8):968-78. PubMed ID: 19509409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The test of infant motor performance: reliability in spinal muscular atrophy type I.
    Finkel RS; Hynan LS; Glanzman AM; Owens H; Nelson L; Cone SR; Campbell SK; Iannaccone ST;
    Pediatr Phys Ther; 2008; 20(3):242-6. PubMed ID: 18703961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.
    Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L
    Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of telephone administration of the PedsQL Generic Quality of Life Inventory and Neuromuscular Module in spinal muscular atrophy (SMA).
    Dunaway S; Montes J; Montgomery M; Battista V; Koo B; Marra J; De Vivo DC; Hynan LS; Iannaccone ST; Kaufmann P
    Neuromuscul Disord; 2010 Mar; 20(3):162-5. PubMed ID: 20074950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.
    Mayhew JE; Florence JM; Mayhew TP; Henricson EK; Leshner RT; McCarter RJ; Escolar DM
    Muscle Nerve; 2007 Jan; 35(1):36-42. PubMed ID: 16969838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.
    Febrer A; Rodriguez N; Alias L; Tizzano E
    J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep disordered breathing in spinal muscular atrophy.
    Mellies U; Dohna-Schwake C; Stehling F; Voit T
    Neuromuscul Disord; 2004 Dec; 14(12):797-803. PubMed ID: 15564035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical presentations of spinal muscular atrophy type III (Kugelberg-Welander disease).
    Kang PB; Krishnamoorthy KS; Jones RM; Shapiro FD; Darras BT
    Neuromuscul Disord; 2006 Aug; 16(8):492-4. PubMed ID: 16797181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle strength and motor function in children and adolescents with spinal muscular atrophy II and III.
    Kroksmark AK; Beckung E; Tulinius M
    Eur J Paediatr Neurol; 2001; 5(5):191-8. PubMed ID: 11585107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spinal muscular atrophy. A 4-year prospective, multicenter, longitudinal study (168 cases)].
    Barois A; Mayer M; Desguerre I; Chabrol B; Berard C; Cuisset JM; Leclair-Richard D; Visconti-Lougovoy J; Hatton F; Estournet-Mathiaud B
    Bull Acad Natl Med; 2005 Jun; 189(6):1181-98; discussion 1198-9. PubMed ID: 16433443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients.
    O'Hagen JM; Glanzman AM; McDermott MP; Ryan PA; Flickinger J; Quigley J; Riley S; Sanborn E; Irvine C; Martens WB; Annis C; Tawil R; Oskoui M; Darras BT; Finkel RS; De Vivo DC
    Neuromuscul Disord; 2007 Oct; 17(9-10):693-7. PubMed ID: 17658255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study.
    Kirschner J; Schorling D; Hauschke D; Rensing-Zimmermann C; Wein U; Grieben U; Schottmann G; Schara U; Konrad K; Müller-Felber W; Thiele S; Wilichowski E; Hobbiebrunken E; Stettner GM; Korinthenberg R
    Neuromuscul Disord; 2014 Feb; 24(2):134-42. PubMed ID: 24300782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of hand-held dynamometry in spinal muscular atrophy.
    Merlini L; Mazzone ES; Solari A; Morandi L
    Muscle Nerve; 2002 Jul; 26(1):64-70. PubMed ID: 12115950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of motor control in patients with proximal childhood spinal muscle atrophy (pilot study).
    Bojakowski J; Dimitrijevic MR; Hausmanowa-Petrusewicz I; Sherwood AM; Wawro AW; Zalewska E
    Electromyogr Clin Neurophysiol; 1993 Sep; 33(6):375-83. PubMed ID: 8223338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of SMA IIIb: muscle strength decreases in a predictable sequence and magnitude.
    Deymeer F; Serdaroglu P; Parman Y; Poda M
    Neurology; 2008 Aug; 71(9):644-9. PubMed ID: 18725590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic study of spinal muscular atrophies in Oman.
    Koul R; Al Futaisi A; Chacko A; Rao V; Simsek M; Muralitharan S; Ganguly SS; Bayoumi R
    J Child Neurol; 2007 Oct; 22(10):1227-30. PubMed ID: 17940251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.